Disclosures for "Progressive Multifocal Leukoencephalopathy (PML) Treated with Pembrolizumab in an AIDS Patient Who Received Recent Immunosuppressive Chemotherapy for EBV-Associated Lymphoma"
-
Dr. Gill has nothing to disclose.
-
The institution of Dr. Ostrow has received research support from NINDS. The institution of Dr. Ostrow has received research support from CDC National ALS Registry (ATSDR).